This board is highly disciplined and experienced. They are always 10 steps ahead and they won’t make stupid decisions that disadvantage shareholders.
I’ve used this pullback in the general market to build on my holding because I’m extremely confident in the clinical work to date and the leadership of this board. As you stated perfectly, this is exactly what you want to see in a leadership team.
IHL Price at posting:
42.0¢ Sentiment: Buy Disclosure: Held